vs
Side-by-side financial comparison of MICROVISION, INC. (MVIS) and Vir Biotechnology, Inc. (VIR). Click either name above to swap in a different company.
Vir Biotechnology, Inc. is the larger business by last-quarter revenue ($240.0K vs $223.0K, roughly 1.1× MICROVISION, INC.). On growth, MICROVISION, INC. posted the faster year-over-year revenue change (-86.5% vs -89.9%). MICROVISION, INC. produced more free cash flow last quarter ($-59.4M vs $-167.9M). Over the past eight quarters, MICROVISION, INC.'s revenue compounded faster (-51.7% CAGR vs -88.0%).
MicroVision Inc. is a technology company specializing in advanced LiDAR sensors, miniature display solutions, and perception software. Its core products serve automotive ADAS, augmented reality devices, consumer electronics, and industrial automation markets, delivering high-precision, low-power sensing technologies for next-generation smart applications.
Vir Biotechnology, Inc. is a clinical-stage immunology company focused on developing innovative therapies and vaccines to address serious infectious diseases including COVID-19, hepatitis B, HIV, and influenza. It operates primarily in the global biopharmaceutical market, collaborating with leading industry partners to advance its pipeline of targeted immune-based solutions for patient populations worldwide.
MVIS vs VIR — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $223.0K | $240.0K |
| Net Profit | — | $-163.1M |
| Gross Margin | — | — |
| Operating Margin | — | -72267.9% |
| Net Margin | — | -67975.4% |
| Revenue YoY | -86.5% | -89.9% |
| Net Profit YoY | -21.2% | 23.7% |
| EPS (diluted) | — | $-1.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $223.0K | — | ||
| Q3 25 | $241.0K | $240.0K | ||
| Q2 25 | $155.0K | $1.2M | ||
| Q1 25 | $589.0K | $3.0M | ||
| Q4 24 | $1.6M | $12.4M | ||
| Q3 24 | $190.0K | $2.4M | ||
| Q2 24 | $1.9M | $3.1M | ||
| Q1 24 | $956.0K | $56.4M |
| Q4 25 | — | — | ||
| Q3 25 | $-14.2M | $-163.1M | ||
| Q2 25 | $-14.2M | $-111.0M | ||
| Q1 25 | $-28.8M | $-121.0M | ||
| Q4 24 | $-31.2M | — | ||
| Q3 24 | $-15.5M | $-213.7M | ||
| Q2 24 | $-23.9M | $-138.4M | ||
| Q1 24 | $-26.3M | $-65.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 99.1% | ||
| Q1 25 | 6.6% | — | ||
| Q4 24 | -149.5% | — | ||
| Q3 24 | — | 97.9% | ||
| Q2 24 | 18.2% | 98.3% | ||
| Q1 24 | -33.6% | 99.9% |
| Q4 25 | — | — | ||
| Q3 25 | -5278.4% | -72267.9% | ||
| Q2 25 | -9455.5% | -9754.3% | ||
| Q1 25 | -2383.7% | -4602.5% | ||
| Q4 24 | -1119.5% | — | ||
| Q3 24 | -8266.3% | -9718.7% | ||
| Q2 24 | -1296.4% | -5158.7% | ||
| Q1 24 | -2793.9% | -142.0% |
| Q4 25 | — | — | ||
| Q3 25 | -5899.2% | -67975.4% | ||
| Q2 25 | -9180.0% | -9139.9% | ||
| Q1 25 | -4886.1% | -3989.6% | ||
| Q4 24 | -1888.2% | — | ||
| Q3 24 | -8166.8% | -8979.7% | ||
| Q2 24 | -1259.5% | -4500.1% | ||
| Q1 24 | -2752.4% | -115.8% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.05 | $-1.17 | ||
| Q2 25 | $-0.06 | $-0.80 | ||
| Q1 25 | $-0.12 | $-0.88 | ||
| Q4 24 | $-0.15 | — | ||
| Q3 24 | $-0.07 | $-1.56 | ||
| Q2 24 | $-0.11 | $-1.02 | ||
| Q1 24 | $-0.13 | $-0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.9M | $497.8M |
| Total DebtLower is stronger | $19.2M | — |
| Stockholders' EquityBook value | $55.5M | $796.1M |
| Total Assets | $103.1M | $1.0B |
| Debt / EquityLower = less leverage | 0.35× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.9M | — | ||
| Q3 25 | $99.5M | $497.8M | ||
| Q2 25 | $91.4M | $598.7M | ||
| Q1 25 | $69.0M | $790.9M | ||
| Q4 24 | $74.7M | $901.0M | ||
| Q3 24 | $43.2M | $909.0M | ||
| Q2 24 | $56.6M | $1.1B | ||
| Q1 24 | $73.1M | $1.1B |
| Q4 25 | $19.2M | — | ||
| Q3 25 | $29.0M | — | ||
| Q2 25 | $32.3M | — | ||
| Q1 25 | $30.1M | — | ||
| Q4 24 | $33.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $55.5M | — | ||
| Q3 25 | $90.7M | $796.1M | ||
| Q2 25 | $77.1M | $947.5M | ||
| Q1 25 | $53.2M | $1.0B | ||
| Q4 24 | $48.8M | $1.2B | ||
| Q3 24 | $65.9M | $1.2B | ||
| Q2 24 | $78.7M | $1.4B | ||
| Q1 24 | $93.8M | $1.5B |
| Q4 25 | $103.1M | — | ||
| Q3 25 | $150.8M | $1.0B | ||
| Q2 25 | $140.6M | $1.2B | ||
| Q1 25 | $116.7M | $1.3B | ||
| Q4 24 | $121.2M | $1.4B | ||
| Q3 24 | $88.3M | $1.5B | ||
| Q2 24 | $103.4M | $1.7B | ||
| Q1 24 | $124.2M | $1.8B |
| Q4 25 | 0.35× | — | ||
| Q3 25 | 0.32× | — | ||
| Q2 25 | 0.42× | — | ||
| Q1 25 | 0.57× | — | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-58.7M | $-167.6M |
| Free Cash FlowOCF − Capex | $-59.4M | $-167.9M |
| FCF MarginFCF / Revenue | -26636.3% | -69952.9% |
| Capex IntensityCapex / Revenue | 304.5% | 132.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-103.1M | $-824.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-58.7M | — | ||
| Q3 25 | $-16.5M | $-167.6M | ||
| Q2 25 | $-12.7M | $-120.2M | ||
| Q1 25 | $-14.1M | $-78.1M | ||
| Q4 24 | $-15.1M | $-446.4M | ||
| Q3 24 | $-14.1M | $-171.5M | ||
| Q2 24 | $-18.6M | $-77.8M | ||
| Q1 24 | $-20.8M | $-109.4M |
| Q4 25 | $-59.4M | — | ||
| Q3 25 | $-16.6M | $-167.9M | ||
| Q2 25 | $-12.9M | $-122.8M | ||
| Q1 25 | $-14.2M | $-79.7M | ||
| Q4 24 | $-15.2M | $-453.7M | ||
| Q3 24 | $-14.1M | $-174.2M | ||
| Q2 24 | $-18.8M | $-78.5M | ||
| Q1 24 | $-20.9M | $-111.3M |
| Q4 25 | -26636.3% | — | ||
| Q3 25 | -6894.6% | -69952.9% | ||
| Q2 25 | -8346.5% | -10111.8% | ||
| Q1 25 | -2410.4% | -2630.1% | ||
| Q4 24 | -918.7% | -3666.2% | ||
| Q3 24 | -7421.1% | -7321.3% | ||
| Q2 24 | -989.5% | -2553.3% | ||
| Q1 24 | -2183.4% | -197.4% |
| Q4 25 | 304.5% | — | ||
| Q3 25 | 53.1% | 132.1% | ||
| Q2 25 | 134.2% | 209.1% | ||
| Q1 25 | 16.8% | 53.7% | ||
| Q4 24 | 6.2% | 59.0% | ||
| Q3 24 | 4.7% | 116.3% | ||
| Q2 24 | 8.7% | 21.7% | ||
| Q1 24 | 11.9% | 3.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
